With the purpose of detecting spontaneous variation of systolic time intervals (STI), 20 normal subjects have been examined and the STI has been recorded for 5 consecutive days at the beginning of the test and 20, 40 and 60 min afterwards. Significant differences were found for PEP, LVET and the PEP/LVET ratio between observations (p < 0.05) and between days (p < 0.01). All the values of the STI at the fifth day are rather near the values recorded at the last observation of the first day. This may be related to the presence of some factor (catecholamine release induced by emotional stress?) resulting in physiological changes which are reduced by repetition of the test. This hypothesis was confirmed in a second series of normal volunteers where the STI were recorded simultaneously with sampling of blood for assessing circulating CA levels. A highly significant correlation (p < 0.001) was recorded between PEP, PEP/LVET and plasma CA making it evident that the increase of PEPI and PEP/LVET is directly correlated with the reduction of plasma CA level.

Keywords:
Noninvasive techniques, Left ventricular function, Preejection period, Left ventricular ejection time
This content is only available via PDF.
© 1982 S. Karger AG, Basel
1982
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.